Overview

Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty

Status:
NOT_YET_RECRUITING
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the impact of an extended oral Tranexamic Acid regimen on patient reported outcome scores, time to independent ambulation, postoperative range of motion, swelling, change in hemoglobin levels, 90-day complications, readmission and reoperation.
Phase:
PHASE4
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Tranexamic Acid